Literature DB >> 6405774

Transplacental passage and half-life of sodium valproate in infants born to epileptic mothers.

S Kaneko, K Otani, Y Fukushima, T Sato, Y Nomura, Y Ogawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6405774      PMCID： PMC1427804          DOI： 10.1111/j.1365-2125.1983.tb01541.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

1.  Effect of sodium valproate on plasma protein binding of diphenylhydantoin.

Authors:  P N Patsalos; P T Lascelles
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-06       Impact factor: 10.154

2.  Sodium valproate and pregnancy.

Authors:  F W Alexander
Journal:  Arch Dis Child       Date:  1979-03       Impact factor: 3.791

3.  Pharmacokinetics and bioavailability of sodium valproate.

Authors:  U Klotz; K H Antonin
Journal:  Clin Pharmacol Ther       Date:  1977-06       Impact factor: 6.875

4.  Concentration of dipropylacetate in plasma.

Authors:  P Loiseau; A Brachet; P Henry
Journal:  Epilepsia       Date:  1975-11       Impact factor: 5.864

5.  [A study on anticonvulsant level in body fluids. 2nd report: Dialyzed serum (free form), CSF and saliva level (author's transl)].

Authors:  S Kaneko
Journal:  Seishin Shinkeigaku Zasshi       Date:  1978-01-25

6.  Transmission of valproic acid (Depakene) across the placenta: half-life of the drug in mother and baby.

Authors:  R G Dickinson; R C Harland; R K Lynn; W B Smith; N Gerber
Journal:  J Pediatr       Date:  1979-05       Impact factor: 4.406

7.  Steady-state kinetics of valproic acid in epileptic patients.

Authors:  J Bruni; B J Wilder; L J Willmore; R J Perchalski; H J Villarreal
Journal:  Clin Pharmacol Ther       Date:  1978-09       Impact factor: 6.875

8.  Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse.

Authors:  W Löscher
Journal:  J Pharmacol Exp Ther       Date:  1978-02       Impact factor: 4.030

9.  Pharmacokinetics of di-n-propylacetate in epileptic patients.

Authors:  F Schobben; E van der Kleijn; F J Gabreëls
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953
  9 in total
  4 in total

1.  Placental transfer and neonatal elimination of mono-unsaturated metabolites of valproic acid.

Authors:  T Kondo; K Otani; T Hirano; S Kaneko
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

2.  Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET.

Authors:  Sung Won Kim; Jacob M Hooker; Nicola Otto; Khaing Win; Lisa Muench; Colleen Shea; Pauline Carter; Payton King; Alicia E Reid; Nora D Volkow; Joanna S Fowler
Journal:  Nucl Med Biol       Date:  2013-07-29       Impact factor: 2.408

3.  Differential transplacental binding of valproic acid: influence of free fatty acids.

Authors:  F Albani; R Riva; M Contin; A Baruzzi; M Altomare; G P Merlini; E Perucca
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

Review 4.  Placental transfer of drugs administered to the mother.

Authors:  G M Pacifici; R Nottoli
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.